Original Research
Accepted on 04 Apr 2025
Immune Architecture in Stage III and IV Melanoma Identifies Distinct Patient Subgroups
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560778
Type at least 3 characters
7,442 articles
Correction
Accepted on 04 Apr 2025
Corrigendum: Extracellular vesicles from human breast cancerresistant cells promote acquired drug resistance and proinflammatory macrophage response
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1595885
Review
Accepted on 04 Apr 2025
The mechanism of action and therapeutic potential of tumor-associated macrophages in tumor immune evasion
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1545928
Original Research
Accepted on 04 Apr 2025
Clinical Manifestations and Risk Factors of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1 Inhibitors: A Case-Control Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1581057
Original Research
Accepted on 04 Apr 2025
Quantifying treatment response to a macrophage-targeted therapy in combination with immune checkpoint inhibitors after exposure to conventional chemotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1565953
Original Research
Accepted on 04 Apr 2025
A predictive model for the transformation from cervical inflammation to cancer based on tumor immune-related factors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1532048
Original Research
Accepted on 04 Apr 2025
To Determine the Role of TRIT1 in the Diagnosis, Prognosis and Immunoinvasion of Liver Hepatocellular Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563442
Original Research
Published on 04 Apr 2025
Clinical potential and experimental validation of prognostic genes in hepatocellular carcinoma revealed by risk modeling utilizing single cell and transcriptome constructs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1541252
Case Report
Published on 04 Apr 2025
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563736
Review
Published on 04 Apr 2025
Single-cell and spatial transcriptomic insights into glioma cellular heterogeneity and metabolic adaptations
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1561388
Review
Published on 04 Apr 2025
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1565278
- 101 views
Original Research
Published on 04 Apr 2025
Development and validation of a disulfidptosis-related genes signature for predicting outcomes and immunotherapy in acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1513040
Original Research
Published on 04 Apr 2025
Identification and validation of HOXC6 as a diagnostic biomarker for Ewing sarcoma: insights from machine learning algorithms and in vitro experiments
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1449355
Review
Published on 04 Apr 2025
A novel cancer-associated lncRNA, LINC01123, participates in tumor progression, metabolism, immune escape, and resistance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1480447
Original Research
Published on 04 Apr 2025
HLA-mismatched stem cell microtransplant prolonged overall survival and promoted immunological reconstitution for multiple myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1509588
Original Research
Accepted on 03 Apr 2025
Identification and Functional Characterization of Prognosis-Related Ferroptosis-Associated lncRNAs in Colorectal Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1561210